Serum KL-6 level and pulmonary function in preterm infants with chronic lung disease

Kobe Journal of Medical Sciences

Volumn 50, Issue 5, 2004, Pages 131-140

  Yamane, Masayuki ^a   Yokoyama, Naoki ^a  

^a KOBE UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Chronic lung disease; Pulmonary function; Serum KL 6; Static respiratory system compliance

Indexed keywords

GLYCOPROTEIN;

ARTICLE; ARTIFICIAL VENTILATION; BLOOD SAMPLING; CHEMOLUMINESCENCE; CHRONIC LUNG DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GESTATIONAL AGE; HUMAN; IMMUNOASSAY; INFANT; LUNG FUNCTION; MALE; NEWBORN INTENSIVE CARE; PERINATAL PERIOD; PREMATURITY; PROTEIN BLOOD LEVEL; RESPIRATORY SYSTEM; TIME SERIES ANALYSIS;

ANTIGENS; ANTIGENS, NEOPLASM; CHRONIC DISEASE; FEMALE; GESTATIONAL AGE; GLYCOPROTEINS; HUMANS; INFANT, NEWBORN; INFANT, PREMATURE; LUNG; LUNG DISEASES; MALE; MUCINS; RESPIRATION, ARTIFICIAL;

EID: 24644433255     PISSN: 00232513     EISSN: 18830498     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Arai,Y., Obinata, K., Sato, Y., Hisaka, K., Tadokoro, R., Tawa, T. et al. 2001. Clinical significance of the serum surfactant protein D and KL-6 levels in patients with measles complicated by interstitial pneumonia. Eur J Pediatr 160:425-429.
2. Goetzman, BW. 1986. Understanding Bronchopulmanary Dysplasia. Am J Dis Child 140:332-334
3. Kobayashi, J., Kitamura, S. 1995. KL-6: A serum marker for interstitial pneumonia. Chest 108:311-315.
4. Kohno, N., Akiyama, M., Koizumi, S., Hakoda, M., Kobuke, S., Yamakido, M. 1988. Detection of soluble tumor associated antigens in sera and effusions using novel monoclonal antibodies, KL-3 and KL-6 antigen against lung adeno-carcinoma. Jpn J Clin Oncol 18:203-216.
5. Kohno, N., Awaya, Y., Oyama, T., Yamakido, M., Akiyama, M., Inoue, Y. et al. 1993. KL-6, a mucin-like glycoprotein, in bronchoalveolar lavage fluid from patients with interstitial lung disease. Am Rev Respir Dis 148:637-42.
6. Kohno, N., Kyoizumi, S., Awaya, Y., Fukuhara, H., Yamakido, M., Akiyama, M. 1989. New serum indicator of interstitial pneumonitis activity. Sialylated carbohydrate antigen KL-6. Chest 96:68-73.
7. Kuroki, Y., Takahashi, H., Chiba, H., Akino, T. 1998. Surfactant proteins A and D: disease markers. Biochim Biophys Acta 1408:334-345
8. Manabe, C., Yoshii, K., Nakao, H., Mizobuchi, M., Yonetani, M., Uetani, Y. et al. 2001. Risk factors for extubation failure in infants with chronic lung disease; usefulness of pulmonary function test for extubation criteria. J Jap Soc for Premature and Newborn Med 13:59-65 (in Japanese).
9. Ogawa, Y., Shimizu, H., Takasaki, J., Nakamura, T. 1999. Strategy for the prevention and treatment of chronic lung disease of the premature infant. Pediatr Pulmonol Suppl 18:212-215.
10. Ogihara, T., Hirano, K., Morinobu, T., Ogawa, S., Hirai, M., Ban, R. 2000. KL-6, a mucinous glycoprotein, as an indicator of chronic lung disease of the newborn. J Pediatr 137:280-282.
11. Sano, Y., Yamazaki, T., Miyata, M., Suzuki, K., Kobayashi, A. 2002. Soluble adhesion molecule and KL-6 in preterm infants with respiratory distress. J Jap Soc for Premature and Newborn Medicine 14:53-60 (in Japanese).
12. Takahashi, Y., Tabata, Y., Okada, Y., Shikano, K., Anakura, M. 2001. Assesment of serum KL-6 levels in patients with adenovirus pneumonia. J Jap Pediatr Soc 105:770-774.
13. Tarnow-Mordi, WO., Wilkie RA., Reid, E. 1994. Static respiratory compliance in the newborn. I: A clinical and prognostic index for mechanically ventilated infants. Arch Dis Child Fetal Neonatal Ed 70:F11-15.
14. Wilkie, RA., Bryan, MH., Tarnow-Mordi, WO. 1994. Static respiratory compliance in the newborn. II: Its potential for improving the selection of infants for early surfactant treatment. Arch Dis Child Fetal Neonatal Ed 70:F16-18.
15. Yokoyama, A., Kohno, N., Hamada, H., Sakatani, M., Ueda, E., Kondo, K. et al. 1998. Circulating KL-6 predicts the outcome of rapidly progressive idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 158:1680-1684.